Fidia S.p.A. (BIT:FDA)
Italy
· Delayed Price · Currency is EUR | Market Cap | 931.89K |
| Revenue (ttm) | 29.17M |
| Net Income (ttm) | -6.44M |
| Shares Out | 388.29M |
| EPS (ttm) | -0.44 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 44,585,128 |
| Average Volume | 30,107,138 |
| Open | 0.0022 |
| Previous Close | 0.0024 |
| Day's Range | 0.0020 - 0.0022 |
| 52-Week Range | 0.0020 - 0.8600 |
| Beta | -0.16 |
| RSI | 31.95 |
| Earnings Date | May 15, 2025 |
About Fidia
Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. Its accessories comprise HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; K5 tracer, a solution to perform continuous scanning of 3D surfaces; pushbutton panels; XPower digital drives for axis and spindle movement; and... [Read more]
Financial Performance
Financial StatementsNews
US Listeria Outbreak: California company removes food from shelves after 10 hospitalised
A Listeria outbreak traced to Fresh and Ready Foods in California has led to ten hospitalizations across California and Nevada. The FDA identified Listeria monocytogenes in the company's facility, mat...
Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio?
These large-cap stocks were the worst performers in the last week. Are they in your portfolio? argenx SE (NASDAQ: ARGX) shares tumbled 15.40% after the company reported first-quarter results . Vertex...
First at-home HPV test approved by FDA, could replace Pap smear
The first at-home cervical cancer screening test has been approved by the Food and Drug Administration, according to the product's manufacturer. It may offer an alternative to traditional in-person Pa...
What to know about the first at-home Pap smear approved by the FDA
The wand developed by Teal Health allows patients to self-collect a vaginal sample and mail it to a lab for testing.
FDA will allow new color additives made from minerals, algae and flower petals
The new food colors will be approved for use in a range of foods from fruit drinks and yogurt to pretzels, ready-to-eat chicken and candies.
FDA approves first at-home test for cervical cancer screening
Teal Health offers alternative to pap smear tests that need to be undertaken at a doctor’s office, slated for June rollout The US Food and Drug Administration (FDA) has approved the first at-home test...
Trump Appointed Martin Makary Targets Faster Drug Approvals With FDA Artificial Intelligence Overhaul
On Thursday, U.S. Food and Drug Administration (FDA) Commissioner Martin A. Makary announced an aggressive timeline to scale the use of artificial intelligence (AI) internally across all FDA centers b...
Serena-backed health tech lands first FDA approval for home cervical cancer test
For the first time, the FDA has just approved a device that lets people screen for cervical cancer from home. Known as the Teal Wand, from the company Teal Health, the prescription device lets patient...
New FDA Leadership Could Raise The Bar For Drug Approvals
Introduction New FDA Leadership Team: The FDA's top leadership has shifted under Commissioner Dr. Marty Makary, with Dr. Vinayak "Vinay" Prasad now heading the Center for Biologics Evaluation and Rese...
InspireMD outlines Q3 2025 FDA approval target for CGuard Prime
MeiraGTx gets FDA RMAT status for its Parkinson’s disease treatment
Startup Teal Health wins FDA approval for at-home test for cervical cancer screening
In clinical trials, the accuracy of self-testing with Teal's wand matched that of a cancer screening performed in a doctor's office.
Teal Health CEO on FDA approval of new at-home cancer test
Kara Egan founded Teal Health during the pandemic, looking to make it easier for women to get preventive cervical cancer screening more easily. Five years later, the FDA has approved the startups self...
FDA approves at-home HPV test to screen for cervical cancer
The Food and Drug Administration on Friday approved the first at-home test to screen for cervical cancer, Teal Health, which makes the test kit, said.
Top 3 Health Care Stocks That Are Preparing To Pump This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go ...
Daly: Bringing back manufacturing has been a priority before Trump
Catalyst Pharma CEO Richard Daly says reshoring drug production shields them from tariffs. He supports FDA plans to speed rare disease drug approvals, calling it a boost for the orphan community.
FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
VANCOUVER, BC , May 8, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, released i...
Cingulate Inc. Reports First Quarter 2025 Financial Results and Provides an Updated Timeline of Key Developments for its lead ADHD and Anxiety Assets
Pre-NDA Meeting for CTx-1301(dexmethylphenidate) Held April 2, 2025; New Drug Application Submission Targeted for Mid-2025 Non-Dilutive Funding to Accelerate Development of CTx-2103 (buspirone) KANSAS...
Nektar Therapeutics Reports First Quarter 2025 Financial Results
SAN FRANCISCO , May 8, 2025 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today reported financial results for the first quarter ended March 31, 2025 . Cash and investments in marketable securit...
Viatris Discloses Positive Data From 2 Drugs In Earnings Report, Stock Soars
Viatris Inc . (NASDAQ: VTRS) on Thursday, released data from Phase 3 study evaluating the contraceptive efficacy and safety of XULANE LO low dose weekly dermal patch of 150 mcg norelgestromin and 17....
FDA to speed up AI rollout to accelerate drug reviews
FDA Grants Accelerated Approval To Verastem's Combination Drug For Ovarian Cancer
The Food and Drug Administration on Thursday granted accelerated approval to Verastem Inc.’s (NASDAQ: VSTM) Avmapki Fakzynja Co-pack, a combination of avutometinib and defactinib for adult patients w...
Verastem's Avmapki Fakzynja receives FDA accelerated approval for ovarian cancer
FDA advisory panel to discuss makeup of updated COVID shots
Novo Nordisk Says Its 'Wegovy In A Pill' Delivers Big: '16.6% Average' Weight Loss, Over 20% For One-Third Of Adults Struggling With Obesity
Novo Nordisk A/S (NYSE: NVO) is seeking FDA approval for the pill version of its obesity drug, Wegovy. The company recently highlighted early data that shows safety and efficacy figures that are simi...